Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The company owns 331 home health care centers, 175 hospice care centers and 14 personal-care, and 8 high acuity care centers.
Market Cap | 3.07 Billion | Shares Outstanding | 32.633 Million | Avg 30-day Volume | 249.103 Thousand |
P/E Ratio | 1158.0119 | Dividend Yield | 0.0 | EPS | 0.79 |
Price to Revenue | 1.3765 | Debt to Equity | 0.3678 | EBITDA | 92.474 Million |
Price to Book Value | 2.9487 | Operating Margin | 7.5695 | Enterprise Value | 3.428 Billion |
Current Ratio | 0.998 | EPS Growth | -0.984 | Quick Ratio | 0.85 |
1 Yr BETA | 0.3564 | 52-week High/Low | 106.02 / 69.37 | Profit Margin | 0.0714 |
Operating Cash Flow Growth | 20.6978 | Free Cash Flow to Firm (FCFF) TTM | 97.67 Million | Free Cash Flow to Equity (FCFE) TTM | |
Altman Z-Score | 3.6826 | ||||
Earnings Report | 2024-02-14 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
HOLTON ADAM Y CHIEF PEOPLE OFFICER |
|
6,035 | 2023-10-20 | 2 |
GUIDROZ ALLYSON CHIEF ACCOUNTING OFFICER |
|
5,136 | 2023-08-24 | 1 |
MUSCATO NICK CHIEF STRATEGY OFFICER |
|
15,537 | 2023-07-25 | 3 |
GINN SCOTT G EVP, CFO & ACTING COO |
|
72,556 | 2023-06-26 | 3 |
ASHWORTH RICHARD M PRESIDENT AND CEO |
|
74,392 | 2023-06-26 | 3 |
BOHNERT DENISE M. CHIEF COMPLIANCE OFFICER |
|
11,954 | 2023-06-10 | 3 |
|
20,729 | 2023-05-03 | 1 | |
|
6,450 | 2023-05-03 | 1 | |
|
5,450 | 2023-05-03 | 1 | |
|
12,663 | 2023-05-03 | 1 | |
|
5,967 | 2023-05-03 | 1 | |
|
6,450 | 2023-05-03 | 1 | |
|
4,232 | 2023-05-03 | 1 | |
|
436,377 | 2023-04-10 | 4 | |
NORTH MICHAEL PAUL CHIEF INFORMATION OFFICER |
|
4,621 | 2023-03-03 | 3 |
KEMMERLY DAVID L SEE REMARKS |
|
16,842 | 2022-03-29 | 0 |
GERARD CHRISTOPHER PRESIDENT & COO |
|
86,142 | 2022-02-17 | 0 |
BRUNECZ SHARON CHIEF HUMAN RESOURCES OFFICER |
|
53,143 | 2022-02-17 | 0 |
|
9,543 | 2021-11-30 | 0 | |
|
71,700 | 2019-12-10 | 0 | |
|
36,698 | 2019-11-13 | 0 | |
PEARCE DAVID B. CHIEF COMPLIANCE OFFICER |
|
5,865 | 2019-08-05 | 0 |
|
17,169 | 2018-11-09 | 0 | |
SENDER SUSAN SEE REMARKS |
|
12,632 | 2018-09-27 | 0 |
|
18,353 | 2018-06-06 | 0 | |
|
No longer subject to file | 2018-06-04 | 0 | |
SEIM STEPHEN CHIEF STRATEGY OFFICER |
|
19,658 | 2018-02-20 | 0 |
PERNOSKY LAWRENCE R CHIEF HUMAN RESOURCES OFFICER |
|
19,107 | 2018-02-20 | 0 |
LABORDE RONALD A VICE CHAIRMAN |
|
No longer subject to file | 2017-04-01 | 0 |
WILLIS GARY D CHIEF FINANCIAL OFFICER |
|
18,878 | 2017-01-20 | 0 |
HOWARD MARTIN B CHIEF INFORMATION OFFICER |
|
No longer subject to file | 2016-10-31 | 0 |
CARMODY JANE SEE REMARKS |
|
No longer subject to file | 2016-08-05 | 0 |
JETER JEFFREY D CHIEF COMPLIANCE OFFICER |
|
No longer subject to file | 2016-07-01 | 0 |
MCCOY DANIEL P CHIEF OPERATING OFFICER |
|
21,988 | 2016-06-04 | 0 |
|
No longer subject to file | 2015-11-03 | 0 | |
|
76,600 | 2015-05-05 | 0 | |
BUCEY DAVID R GENERAL COUNSEL AND SECRETARY |
|
24,898 | 2015-04-01 | 0 |
FLEMING MICHAEL O. CHIEF MEDICAL OFFICER |
|
21,107 | 2015-04-01 | 0 |
|
88,021 | 2014-07-01 | 0 | |
REDMAN DALE E INTERIM CFO |
|
0 | 2014-03-24 | 0 |
BORNE WILLIAM F CHIEF EXECUTIVE OFFICER / |
|
483,548 | 2013-04-01 | 0 |
BARFIELD T A JR CHIEF DEVELOPMENT OFFICER |
|
45,645 | 2011-04-01 | 0 |
SNOW MICHAEL D CHIEF OPERATING OFFICER |
|
41,197 | 2011-04-01 | 0 |
GRAHAM LARRY R COO AND PRESIDENT |
|
14,587 | 2009-07-30 | 0 |
SCHWARTZ ALICE A CHIEF INFORMATION OFFICER |
|
8,207 | 2009-04-01 | 0 |
GIBLIN JOHN F CHIEF FINANCIAL OFFICER |
|
0 | 2006-10-23 | 0 |
LOVERICH DONALD JR PRINCIPAL ACCOUNTING OFFICER |
|
44 | 2006-06-07 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-10-24 19:04:52 -0400 | 2023-10-20 | F | 509 | $92.74 | d | 6,035 | direct | -0.3825 | -0.0656 | 0.0 | 1 | -0.3825 | 2 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
AMEDISYS INC AMED | 2023-11-28 22:15:04 UTC | 5.07 | 0.25 | 700000 |
AMEDISYS INC AMED | 2023-11-28 21:45:03 UTC | 5.07 | 0.25 | 700000 |
AMEDISYS INC AMED | 2023-11-28 21:15:04 UTC | 5.07 | 0.25 | 700000 |
AMEDISYS INC AMED | 2023-11-28 20:45:04 UTC | 5.07 | 0.25 | 700000 |
AMEDISYS INC AMED | 2023-11-28 20:15:04 UTC | 5.07 | 0.25 | 700000 |
AMEDISYS INC AMED | 2023-11-28 19:45:03 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 19:15:04 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 18:45:03 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 18:15:03 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 17:45:04 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 17:15:04 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 16:45:04 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 16:15:04 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 15:45:03 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 15:15:03 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 14:45:04 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 14:15:04 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 13:45:04 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 13:15:03 UTC | 5.07 | 0.25 | 750000 |
AMEDISYS INC AMED | 2023-11-28 12:45:04 UTC | 5.07 | 0.25 | 750000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
FundVantage Trust- Gotham Enhanced Index Plus Fund | AMED | -15.0 shares, $-2753.1 | 2020-03-31 | N-PORT |
FundVantage Trust- Gotham Index Plus All-Cap Fund | AMED | -31.0 shares, $-5689.74 | 2020-03-31 | N-PORT |
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund | AMED | -610.0 shares, $-161521.9 | 2021-03-31 | N-PORT |
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund | AMED | -728.0 shares, $-192767.12 | 2021-03-31 | N-PORT |
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund | AMED | -2960.0 shares, $-286498.4 | 2022-09-30 | N-PORT |
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund | AMED | -871.0 shares, $-79121.64 | 2023-07-31 | N-PORT |